文献速递技术与安全腹部US

六氟化硫微泡在腹部及浅表器官超声造影中的安全性:30222例回顾性分析

Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases.
PubMed 文献 · J Ultrasound Med · 2017-01-10

回顾性分析2005年1月至2014年12月在本院接受腹部及浅表器官超声造影的30222例患者,使用六氟化硫微泡造影剂SonoVue。无患者因不良反应死亡,6例(0.020%)出现不同程度不良反应,其中2例(0.007%)出现早期过敏性休克征象,经积极抢救后好转;其余4例症状休息后自行缓解。结论认为该造影剂临床安全性好,但可见罕见不良反应,应制定全面应急预案和抢救措施。

要点

  • 30222例腹部及浅表器官超声造影中,不良反应发生率0.020%(6例),无死亡。
  • 早期过敏性休克征象发生率0.007%(2例),经积极抢救后好转。
  • 其余4例不良反应包括注射部位上方手臂红肿皮疹、鼻出血伴恶心、恶心呕吐、背痛伴口唇及肢体麻木,休息后自行缓解。

核心结论

  • 六氟化硫微泡超声造影具有良好的临床安全性,但可见罕见不良反应。
  • 应制定全面的应急预案和抢救措施并可供使用,以尽量减少不良临床结局的发生。

研究设计与样本

  • 回顾性研究,纳入2005年1月至2014年12月在本院接受腹部及浅表器官超声造影的30222例患者。
  • 超声造影剂为SonoVue(Bracco SpA,米兰,意大利)。
  • 回顾并分析造影检查期间发生的不良反应症状及治疗。

诊断标准与关键数值

  • 不良反应发生率0.020%(6/30222),其中早期过敏性休克征象发生率0.007%(2/30222)。

临床应用与阅片要点

  • 应制定全面的应急预案和抢救措施并可供使用,以尽量减少不良临床结局的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to investigate the safety of the sulfur hexafluoride microbubble contrast agent SonoVue (Bracco SpA, Milan, Italy) and to implement precautions with the intent of further improving the safety of this contrast agent.

METHODS: A total of 30,222 patients undergoing contrast-enhanced sonography of abdominal and superficial organs in our hospital from January 2005 to December 2014 were retrospectively investigated. SonoVue was used as the ultrasound contrast agent. The symptoms and treatments of adverse reactions occurring during the contrast-enhanced sonographic examinations were reviewed and analyzed.

RESULTS: No patient died as a result of any adverse reaction. Six patients (0.020%) had adverse reactions of varying degrees, including 2 patients (0.007%) who had signs of early anaphylactic shock (chest tightness, palpitations, sweating, and rapid and weak pulse, followed by cyanosis, a disappearing pulse, and a drop in blood pressure) that improved after active rescue. The remaining 4 patients developed the following: redness and a rash on the arm above the injection site, nasal bleeding and nausea, nausea and vomiting, and back pain with numbness of the lips and limbs. Symptoms in these 4 patients self-resolved after a period of rest.

CONCLUSIONS: Contrast-enhanced sonography with sulfur hexafluoride microbubbles had good clinical safety, but rare adverse reactions were observed. A comprehensive emergency plan and rescue measures for adverse reactions should be prepared and made available to minimize the occurrence of negative clinical outcomes.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Tang C, Fang K, Guo Y, et al. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases. J Ultrasound Med. 2017. PMID: 28072475. doi:10.7863/ultra.15.11075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。